113 related articles for article (PubMed ID: 27239051)
1. Can synaptophysin be used as a marker of breast cancer diagnosed by core-needle biopsy in epithelial proliferative diseases of the breast?
Maeda I; Tajima S; Ariizumi Y; Doi M; Endo A; Naruki S; Hoshikawa M; Koizumi H; Kanemaki Y; Ueno T; Tsugawa K; Takagi M
Pathol Int; 2016 Jul; 66(7):369-75. PubMed ID: 27239051
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of computer-aided diagnosis (CADx) of breast pathology using immunohistochemistry results of core needle biopsy samples for synaptophysin, oestrogen receptor and CK14/p63 for classification of epithelial proliferative lesions of the breast.
Maeda I; Kubota M; Ohta J; Shinno K; Tajima S; Ariizumi Y; Doi M; Oana Y; Kanemaki Y; Tsugawa K; Ueno T; Takagi M
J Clin Pathol; 2017 Dec; 70(12):1057-1062. PubMed ID: 28630050
[TBL] [Abstract][Full Text] [Related]
3. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
4. [Ultrasound-guided core needle biopsy in the diagnosis of breast lesions].
Fan ZQ; Ouyang T; Wang TF; Li JF; Xie YT; Fan T; Zhang Z; Lin BY
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1185-7. PubMed ID: 18067713
[TBL] [Abstract][Full Text] [Related]
5. Atypical hyperplasia on core biopsy: is further surgery needed?
Polat AK; Kanbour-Shakir A; Andacoglu O; Polat AV; Johnson R; Bonaventura M; Soran A
Am J Med Sci; 2012 Jul; 344(1):28-31. PubMed ID: 22205116
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.
Shah VI; Flowers CI; Douglas-Jones AG; Dallimore NS; Rashid M
Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684
[TBL] [Abstract][Full Text] [Related]
7. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities.
Sneige N; Tulbah A
Diagn Cytopathol; 2000 Jul; 23(1):29-34. PubMed ID: 10907929
[TBL] [Abstract][Full Text] [Related]
9. Histological evaluation of papillary lesions of the breast from needle biopsy to the excised specimen: a single institutional experience.
Gilani S; Tashjian R; Kowalski P
Pathologica; 2013 Apr; 105(2):51-5. PubMed ID: 23946981
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
[TBL] [Abstract][Full Text] [Related]
11. [Management of non-malignant results in core needle biopsy of breast lesions].
Fan ZQ; Ouyang T; Li JF; Wang TF; Xie YT; Fan T; Zhang Z; Lin BY
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2387-90. PubMed ID: 19087711
[TBL] [Abstract][Full Text] [Related]
12. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
13. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
[TBL] [Abstract][Full Text] [Related]
14. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
15. Benign Papillomas of the Breast Diagnosed on Large-Gauge Vacuum Biopsy compared with 14 Gauge Core Needle Biopsy - Do they require surgical excision?
Seely JM; Verma R; Kielar A; Smyth KR; Hack K; Taljaard M; Gravel D; Ellison E
Breast J; 2017 Mar; 23(2):146-153. PubMed ID: 27797135
[TBL] [Abstract][Full Text] [Related]
16. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
18. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?
Koo JS; Han K; Kim MJ; Moon HJ; Kim EK; Park BW
Breast Cancer Res Treat; 2013 Feb; 137(3):797-806. PubMed ID: 23292118
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
20. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
